An Open-Label Trial to Assess the Comparative Bioavailability of TV-44749 to Oral Olanzapine in Participants with Schizophrenia

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-505664-11-00

Acronym

TV44749-BA-10196

Enrollment

Registered

2024-05-07

Start date

2024-06-19

Completion date

2025-08-11

Last updated

2025-08-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Schizophrenia

None listed

Sex/Gender

All

Age

18 Years to 64 Years

Croatia, France, Germany, Spain

None listed

Source: EU CTIS · Data processed: Feb 4, 2026